Market Research Logo

Global Biosimulation Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021

1. Introduction
1.1 Executive Summary
1.2 Estimation methodology
2. Market overview
2.1 Market definition and scope
2.2 Key findings
2.3 Parametric analysis
2.3.1 Personalized medicine market
2.3.2 Investment in R&D by various organizations
2.3.3 Healthcare expenditure across geographies
2.3.4 Disposable income of top emerging economies
2.4 Key market insights
2.4.1 Top 3 emerging countries
2.4.2 Top 3 revenue generating segments
2.4.3 Market trends
2.4.4 Winning strategy
2.4.5 Pipeline analysis
2.5 R & D Scenario
2.6 Competitive intelligence
2.6.1 Market share analysis
2.6.2 Top winning strategies
2.6.3 Case study; top competitive moves
2.7 Value chain analysis
2.8 Key buying criteria
2.9 Strategic recommendation
2. Strategic conclusion
3. Market determinants
3.1 Market driver
3.1.1 Increased use of personalized medicine
3.1.2 Research and development in the field
3.1.3 Growth in pharmaceutical and biotechnological industries.
3.1.4 Advent of improved simulation and modeling tools
3.1.5 Growing incidence of chronic diseases.
3.2 Market Restraints
3.2.1 Shortage of skilled professionals
3.2.2 High R&D costs of biosimulation software development
3.2.3 Lack of standardized tools and applications
3.3 Market opportunities
3.3.1 Drive in drugs market due to ageing population
3.3.2 Partnership among pharmaceutical players
3.4 Market challenges
3.4.1 Limited knowledge of biological process
3.4.2 Higher cost
4. Sector analysis
4.1 Parent market analysis
4.2 Competitor market analysis
4.3 Alternative market analysis
5. Market Segmentation
5.1 Global Biosimulation market on the basis of products, 2014-2021,($ millions)
5.1.1 Global Biosimulation market on the basis ofservices, 2014-2021,($ millions)
5.1.2 Global Biosimulation market on the basis ofTrial Design software, 2014-2021,($ millions)
5.1.3 Global Biosimulation market on the basis ofPBPK modeling, 2014-2021,($ millions)
5.1.4 Global Biosimulation market on the basis ofToxicity prediction software, 2014-2021,($ millions)
5.1.5 Global Biosimulation market on the basis ofMolecular modeling and simulation software, 2014-2021,($ millions)
5.2 Global Biosimulation market on the basisof end user, 2014-2021($ millions)
5.2.1 Global Biosimulation market on the basis ofResearch institutes , 2014-2021,($ millions)
5.2.2 Global Biosimulation market on the basis ofPharmaceutical biotechnological companies, 2014-2021, ($ millions)
5.2.3 Global Biosimulation market on the basis of Regulatory athourities, 2014-2021,($ millions)
5.3 Global Biosimulation market on the basis of application, 2014-2021 ($ millions)
5.3.1 Global Biosimulation market on the basis ofDrug development, 2014-2021,($ millions)
5.3.2 Global Biosimulation market on the basis of PK/PD, 2014-2021,($ millions)
5.3.3 Global Biosimulation market on the basis ofClinical trials, 2014-2021,($ millions)
5.3.4 Global Biosimulation market on the basis ofLead identification and Optimization, 2014-2021,($ millions)
5.4 Global biosimulation market on the basis of Drug development,2014-2021 ($ millions)
5.4.1 Global Biosimulation market on the basis ofPreclinical testing, 2014-2021,($ millions)
5.4.2 Global Biosimulation market on the basis ofInpatient validation, 2014-2021,($ millions)
6 Geographic analysis
6.1 North America market, 2014-2021,($ millions)
6.1.1 U.S Biosimulation market,2014-2021,($millions)
6.1.2 Canada Biosimulation market,2014 -2021,($millions)
6.2 Europe Biosimulation market,2014 -2021,($millions)
6.2.1 U.K Biosimulation market,2014 -2021,($millions)
6.2.2 Germany Biosimulation market,2014 -2021,($millions)
6.2.3 France Biosimulation market,2014 -2021,($millions)
6.2.4 Spain market Biosimulation,2014 -2021,($millions)
6.2.5 Italy market Biosimulation,2014 -2021,($millions)
6.3 Asia Pacific
6.3.1 China Biosimulation market ,2014 -2021,($millions)
6.3.2 India Biosimulation market,2014 -2021,($millions)
6.3.3 Korea Biosimulation market,2014 -2021,($millions)
6.3.4 Japan Biosimulation market,2014 -2021,($millions)
6.3.5 Australia Biosimulation market,2014 -2021,($millions)
6.3.6 Rest of APAC
6.4 Rest of the world
7. Company Profiling
7.1 Certara USA, Inc.
7.2 Rhenovia Pharma Ltd.
7.3 Physiomics PLC
7.4 Genedata Ag
7.5 Entelos Holding Corporation
7.6 Chemical Computing Group, Inc.
7.7 Advanced Chemistry Development, Inc.
7.8 Schrödinger Inc.
7.9 Dassault Systèmes SA
7.10 Simulation Plus Inc.
7.11 Biovia (Formerly Accelrys)
7.12 In silico biosciences
7.13 Inhibox
7.14 Leadinvent Technologies
7.15 Leadscope
7.16 Nimbus therapeutics
7.17 Open eye Scientific software
7.18 Physiomics Plc.
7.19 Rhenovia Pharma
7. Genedata
List of tables
Global Biosimulation market on the basis of products, 2014-2021,($ millions)
Global Biosimulation market on the basis of products by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofservices by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofTrial Design software by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofPBPK modeling by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofToxicity prediction software by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofMolecular modeling and simulation software by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of end user by geography, 2014-2021($ millions)
Global Biosimulation market on the basis of end user, 2014-2021($ millions)
Global Biosimulation market on the basis ofusage in Research institutes by geogyaphy , 2014-2021,($ millions)
Global Biosimulation market on the basis of usage in Pharmaceutical biotechnological companies by geography, 2014-2021, ($ millions)
Global Biosimulation market on the basis of usage in Regulatory authorities by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of application, 2014-2021 ($ millions)
Global Biosimulation market on the basis of application by geography, 2014-2021 ($ millions
Global Biosimulation market on the basis of Drug development by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of PK/PD by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of Clinical trials by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis ofLead identification and Optimization by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of Drug development by geography,2014-2021 ($ millions)
Global Biosimulation market on the basis of Drug development,2014-2021 ($ millions)
Global Biosimulation market on the basis of Preclinical testing by geography, 2014-2021,($ millions)
Global Biosimulation market on the basis of Inpatient validation by geography, 2014-2021,($ millions)
List of figures
U.S Biosimulation market,2014-2021,($millions)
Canada Biosimulation market,2014 -2021,($millions)
U.K Biosimulation market,2014 -2021,($millions)
Germany Biosimulation market,2014 -2021,($millions)
France Biosimulation market,2014 -2021,($millions)
Spain market Biosimulation,2014 -2021,($millions)
Italy market Biosimulation,2014 -2021,($millions)
China Biosimulation market ,2014 -2021,($millions)
India Biosimulation market,2014 -2021,($millions)
Korea Biosimulation market,2014 -2021,($millions)
Japan Biosimulation market,2014 -2021,($millions)
Australia Biosimulation market,2014 -2021,($millions)
Global Biosimulation market on the basis ofservices, 2014-2021,($ millions)
Global Biosimulation market on the basis ofTrial Design software, 2014-2021,($ millions)
Global Biosimulation market on the basis ofPBPK modeling, 2014-2021,($ millions)
Global Biosimulation market on the basis ofToxicity prediction software, 2014-2021,($ millions)
Global Biosimulation market on the basis ofMolecular modeling and simulation software, 2014-2021,($ millions)
Global Biosimulation market on the basis ofResearch institutes , 2014-2021,($ millions)
Global Biosimulation market on the basis ofPharmaceutical biotechnological companies, 2014-2021, ($ millions)
Global Biosimulation market on the basis of Regulatory athourities, 2014-2021,($ millions)
Global Biosimulation market on the basis ofDrug development, 2014-2021,($ millions)
Global Biosimulation market on the basis of PK/PD, 2014-2021,($ millions)
Global Biosimulation market on the basis ofClinical trials, 2014-2021,($ millions)
Global Biosimulation market on the basis ofLead identification and Optimization, 2014-2021,($ millions)
Global Biosimulation market on the basis ofPreclinical testing, 2014-2021,($ millions)
Global Biosimulation market on the basis ofInpatient validation, 2014-2021,($ millions

Global Biosimulation Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021

Biosimulation market is growing at an impressive CAGR from 2015-2021. With increasing use of personalized medicine and continuous research in the field the Biosimulation market is also growing at a faster rate, some of the big players of the field are Certara, Biovia, Dassault Systèmes inhibox etc.

There are lot of factors driving the market such as advent of improved simulation and modeling tools as a result of continuous research and development in the field, also the increasing integration of the fields with other fields such as pharmaceutical and biotechnological is acting as a growth factor for the industry. With every passing day, number of aging people are increasing and also, increase in chronic diseases can be seen. These factors act as very strong market driver. Due to the lucrative market opportunities, other companies are also trying to enter this market. Regarding this, many collaborations and partnership among pharmaceutical players is seen.

On the other hand, Asia-Pacific is projected to be a fast growing market, due to growing population and increase in number people investing in healthcare

Companies profile include

1. Certara USA, Inc.
2. Rhenovia Pharma Ltd.
3. Physiomics PLC
4. Genedata Ag
5. Entelos Holding Corporation
6. Chemical Computing Group, Inc.
7. Advanced Chemistry Development, Inc.
8. Schrödinger Inc.
9. Dassault Systèmes SA
10. Simulation Plus Inc.
11. Biovia (Formerly Accelrys)
12. In silico biosciences
13. Inhibox
14. Leadinvent Technologies
15. Leadscope
16. Nimbus therapeutics
17. Open eye Scientific software
18. Physiomics Plc.
19. Rhenovia Pharma
20. Genedata

This Occams Research Report covers

1. Historical data
2.Revenue forecasts, growth rates and CAGR up to 2021
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;